Sign inJoin waitlistJoin the waitlist

JF

Juan Frias

Clinical Professor · Charles R Drew University of Medicine and Science, College of Medicine

Credentials: · ·

History

Charles R Drew University of Medicine and Science, College of Medicine
Present

Internal Medicine

Research

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
New England Journal of Medicine · 2021 · First of 10 authors · 1,567 citations
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
New England Journal of Medicine · 2023 · 858 citations
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical…
JAMA · 2021 · 852 citations

JR
Julio Rosenstock
18 papers
VA
Vanita Aroda
10 papers
Serge Jabbour
8 papers
Steven Edelman
8 papers
Ildiko Lingvay
7 papers
LB
Lawrence Blonde
6 papers
SH
Stephen Harrison
6 papers
TB
Timothy Bailey
6 papers
AA
Azazuddin Ahmed
5 papers
William Garvey
5 papers
YK
Yolanta Kruszynska
5 papers
GN
Guy Neff
4 papers

Clinical trials

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Principal investigator · Completed · Phase 2
Elcelyx Therapeutics, Inc.
2015–2016
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2026–2030
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032